363 related articles for article (PubMed ID: 18711901)
1. The rise of foreign agents. Drugs and other medical products from offshore suppliers can offer tremendous savings, but safety has become an increasing concern.
Rhea S
Mod Healthc; 2008 May; 38(21):28-30. PubMed ID: 18711901
[No Abstract] [Full Text] [Related]
2. [Access for all to quality drugs].
Videau JY
Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
[TBL] [Abstract][Full Text] [Related]
3. Making medicines safe.
Videau JY
Bull World Health Organ; 2001; 79(2):87. PubMed ID: 11242826
[No Abstract] [Full Text] [Related]
4. International prices and availability of pharmaceuticals in 2005.
Danzon PM; Furukawa MF
Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
[TBL] [Abstract][Full Text] [Related]
5. Drug importation and safety of drugs obtained from Canada.
Shepherd M
Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
[TBL] [Abstract][Full Text] [Related]
6. Canada's plan to sell generic drugs to developing countries is threatened.
Spurgeon D
BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
[No Abstract] [Full Text] [Related]
7. Economic and technological drivers of generic sterile injectable drug shortages.
Woodcock J; Wosinska M
Clin Pharmacol Ther; 2013 Feb; 93(2):170-6. PubMed ID: 23337525
[TBL] [Abstract][Full Text] [Related]
8. Copycat consolidation.
Wadman M
Nature; 2007 Sep; 449(7161):393. PubMed ID: 17898741
[No Abstract] [Full Text] [Related]
9. Biotechs go generic: the same but different.
Ledford H
Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194
[No Abstract] [Full Text] [Related]
10. Lessons from Eprex for biogeneric firms.
Louët S
Nat Biotechnol; 2003 Sep; 21(9):956-7. PubMed ID: 12949539
[No Abstract] [Full Text] [Related]
11. The high cost of foreign sourcing.
Harding M
Hosp Mater Manage Q; 1997 Aug; 19(1):73-6. PubMed ID: 10168478
[TBL] [Abstract][Full Text] [Related]
12. A study of the capability of manufacturers of generic hormonal contraceptives in lower- and middle-income countries.
Hall PE; Oehler J; Woo P; Zardo H; Chinery L; Singh JS; Jooseery SH; Essah NM
Contraception; 2007 Apr; 75(4):311-7. PubMed ID: 17362712
[TBL] [Abstract][Full Text] [Related]
13. Congress works to permit 'biosimilar' drugs very soon.
Carroll J
Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559
[No Abstract] [Full Text] [Related]
14. Trade systems in less-developed countries.
Kamal Smith M; 't Hoen E
Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386324
[No Abstract] [Full Text] [Related]
15. The other path for follow-ons.
Nat Biotechnol; 2008 Jul; 26(7):715. PubMed ID: 18612272
[TBL] [Abstract][Full Text] [Related]
16. Generic drug company ordered to upgrade.
Lewis C
FDA Consum; 1999; 33(4):37. PubMed ID: 10443182
[No Abstract] [Full Text] [Related]
17. Generic drugs. Save money--but is there a cost?
Roberts SS
Diabetes Forecast; 2002 Nov; 55(11):51-3. PubMed ID: 14768605
[No Abstract] [Full Text] [Related]
18. [More than "cheap copies". Generic drugs promote medical progress].
MMW Fortschr Med; 2004 Jun; 146(24):51. PubMed ID: 15366498
[No Abstract] [Full Text] [Related]
19. Bills target biosimilar drugs.
Wadman M
Nature; 2009 Mar; 458(7237):394-5. PubMed ID: 19325595
[No Abstract] [Full Text] [Related]
20. Comparison of simvastatin tablets from the US and international markets obtained via the Internet.
Veronin MA; Nguyen NT
Ann Pharmacother; 2008 May; 42(5):613-20. PubMed ID: 18413690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
